Shilpa Medicare Limited (NSE: SHILPAMED) has recommended a final dividend of ₹0.60 per equity share for the financial year ended March 31, 2026, as announced by its Board of Directors at a meeting held on May 22, 2026. Separately, the company submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, to the NSE on August 5, 2026.

Dividend Details

The declared final dividend of ₹0.60 per share is payable on equity shares of face value ₹1 each. The dividend represents a 60% payout on face value. With market price data unavailable in the current exchange feed (quote and tradeInfo not disclosed), a precise dividend yield calculation cannot be derived at this time. Investors are advised to compute yield by dividing ₹0.60 by the prevailing market price at the time of the record date announcement.

Dividend History and Trend Analysis

The FY26 dividend of ₹0.60 per share marks a significant reduction from the company's payouts during FY20 through FY22, when Shilpa Medicare consistently declared dividends of ₹1.10 per equity share across three consecutive years. The current payout matches levels last seen during the FY17 interim dividend, also at ₹0.60 per share, and the FY16 interim dividend of ₹0.60 per share.

The data reveals a clear downward trend in dividend payouts since FY22, with no dividend announcements recorded for FY23, FY24, or FY25 in the available exchange data. The FY26 payout, while resuming distributions to shareholders, is 45.5% lower than the ₹1.10 per share paid in each of FY20, FY21, and FY22.

Q1 FY27 Results Filed

Concurrent with the dividend history context, Shilpa Medicare filed its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with the NSE on August 5, 2026. The submission follows the outcome of a Board meeting held on the same date. Detailed financial metrics including revenue, EBITDA, and net profit figures from this quarterly filing were not included in the exchange announcement text and would be available in the full results document on the NSE platform.

Company Background

Shilpa Medicare Limited, identified by ISIN INE790G01023, is a Raichur-based pharmaceutical company engaged in the manufacture of active pharmaceutical ingredients (APIs), oncology formulations, and specialty chemicals. The company serves regulated markets including the US, Europe, and Japan, and has maintained a consistent dividend track record since at least FY15, though with notable gaps and variability in payout quantum over the past decade.

What This Means for Investors

The resumption of dividends after an apparent multi-year gap signals a degree of financial confidence from the board, though the reduced quantum relative to historical highs warrants scrutiny of the underlying earnings trajectory. Investors tracking the stock should note the absence of exchange-disclosed PE ratio, sector PE comparison, 52-week range, and delivery percentage data in the current corporate announcement feed, all of which are material inputs for a complete valuation assessment. Shareholders should watch for the record date announcement to confirm eligibility for the ₹0.60 per share payout.